Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | CMA1 | P23946 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5381801 | 0.86 | TAAR1 (0.49) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL5386460 | 0.84 | TAAR1 (0.46) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL180328 | 0.84 | TAAR1 (0.43) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL5377511 | 0.83 | TAAR1 (0.47) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL5018909 | 0.82 | TAAR1 (0.59) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL104467 | 0.82 | TAAR1 (0.74) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL5372792 | 0.81 | GRIN2D (0.43) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL6567451 | 0.81 | PARP1 (0.57) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL12775573 | 0.79 | TAAR1 (0.56) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 | |
| SCHEMBL14518821 | 0.79 | MAOA (0.47) | TAAR1SLC6A4SLC6A2SLC6A3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104604-A1 | SOLID FRAGRANCE COMPOSITION | FIRMENICH SA (CH) | 2026-05-21 | — | — | WO | claimed |
| EP-4514477-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | Firmenich SA (CH) | 2025-03-05 | — | — | EP | claimed |
| WO-2023247599-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | claimed |
| WO-2026104604-A1 | SOLID FRAGRANCE COMPOSITION | FIRMENICH SA (CH) | 2026-05-21 | — | — | WO | disclosed |
| US-12497577-B2 | Method of countering malodour in a washing machine comprising the addition of a fragrance precursor | GIVAUDAN SA (CH) | 2025-12-16 | — | — | US | disclosed |
| EP-4514477-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | Firmenich SA (CH) | 2025-03-05 | — | — | EP | disclosed |
| EP-4218837-B1 | VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | FIRMENICH & CIE (CH) | 2024-11-27 | — | — | EP | disclosed |
| US-20240309296-A1 | METHOD OF COUNTERING MALODOUR IN A WASHING MACHINE COMPRISING THE ADDITION OF A FRAGRANCE PRECURSOR | GIVAUDAN SA (CH) | 2024-09-19 | — | — | US | disclosed |
| US-12024690-B2 | Method of countering malodour in a washing machine comprising the addition of a fragrance precursor accord comprising 4-(dodecylthio)-4-methylpentan-2-one | GIVAUDAN SA (CH) | 2024-07-02 | — | — | US | disclosed |
| EP-4338761-A1 | PERFUMING COMPOSITIONS | Firmenich SA (CH) | 2024-03-20 | — | — | EP | disclosed |
| WO-2023247599-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | disclosed |
| US-10934240-B2 | Cyclohexene derivatives as perfuming ingredients | FIRMENICH SA (CH) | 2021-03-02 | — | — | US | disclosed |
| WO-2020125922-A1 | A METHOD OF COUNTERING MALODOUR IN A WASHING MACHINE COMPRISING THE ADDITION OF A FRAGRANCE PRECURSOR | GIVAUDAN SA (CH) | 2020-06-25 | — | — | WO | disclosed |
| US-20200071253-A1 | CYCLOHEXENE DERIVATIVES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2020-03-05 | — | — | US | disclosed |
| US-20190343977-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | FIRMENICH SA (CH) | 2019-11-14 | — | — | US | disclosed |
| EP-3541435-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | Firmenich SA (CH) | 2019-09-25 | — | — | EP | disclosed |
| EP-3349862-B1 | A GREEN, LILY OF THE VALLEY PERFUMING INGREDIENT | FIRMENICH & CIE (CH) | 2019-09-04 | — | — | EP | disclosed |
| US-10100267-B1 | Green, lily of the valley perfuming ingredient | FIRMENICH SA (CH) | 2018-10-16 | — | — | US | disclosed |
| US-20180282660-A1 | A GREEN, LILY OF THE VALLEY PERFUMING INGREDIENT | FIRMENICH SA (CH) | 2018-10-04 | — | — | US | disclosed |
| WO-2018091686-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF FECAL MALODOUR | FIRMENICH SA (CH) | 2018-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10100267-B1 | Green, lily of the valley perfuming ingredient | CYCS, ACLY, CYC1 | TAAR1 1864/4885SLC6A4 3627/4885SLC6A2 4681/4885 |
| US-10934240-B2 | Cyclohexene derivatives as perfuming ingredients | C5, C1S, C1R | TAAR1 1502/4885SLC6A4 1693/4885SLC6A2 3578/4885 |
| US-20200071253-A1 | CYCLOHEXENE DERIVATIVES AS PERFUMING INGREDIENTS | C5, C1S, C1R | TAAR1 1502/4885SLC6A4 1693/4885SLC6A2 3578/4885 |
| US-20180282660-A1 | A GREEN, LILY OF THE VALLEY PERFUMING INGREDIENT | CYCS, ACLY, CYC1 | TAAR1 2040/4885SLC6A4 3241/4885SLC6A2 4505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.